The End of the X-Waiver Is a Chance to Advance Health Equity (

On January 12, 2023 the federal government announced an important change to drug policy that should enable greatly expanded access to buprenorphine, a crucial opioid use disorder medication. This change could stem the course of our nation’s devastating opioid-involved overdose epidemic. And it’s a step toward redressing policies that have harmed lower–income communities as well as Black, Indigenous and other people of color.

Read the full article at

« Back to Updates